1. The epidemiology of virus transmission by plasma derivatives: clinical studies verifying the lack of transmission of hepatitis B and C viruses and HIV type 1;Tabor;Transfusion,1999
2. United States Food and Drug Administration. 2009 www.fda.gov/biologicsbloodvaccines/guidancecomplianceregulatoryinformation/guidances/blood/ucm071592. htm
3. A sensitive PCR method for detecting HCV RNA in plasma pools, blood products, and single donations;Saldanha;J Med Virol,1994
4. Committee for Proprietary Medicinal Products 1996 Note for guidance on virus validation studies: The design, contribution and interpretation of studies validating the inactivation and removal of viruses
5. Committee for Proprietary Medicinal Products 2009 Note for guidance on plasma derived medicinal products